RELEASE: Maypharm CO, LTD.: New Multilayer Phasic Hyaluronic Acid Filler with Lidocaine

(Information sent by the signatory company).

RELEASE: Maypharm CO, LTD.: New Multilayer Phasic Hyaluronic Acid Filler with Lidocaine

(Information sent by the signatory company)

-Maypharm CO, LTD., has launched a new CE filler: Multilayer Phasic Hyaluronic Acid with Lidocaine and MayFill Filler with CE approval

SEOUL, South Korea and NEW YORK, Feb. 20, 2023 /PRNewswire/ -- Maypharm, the trademark holder of such popular products as Metoo fill, Sedy fill, Metox, Mennus, Hairna, Eyebella, has been busy with the development of new products in the Aesthetics market. Metoo Fill is the first CE approved filler made by Maypharm and is loved by customers for its excellent volume and high viscosity with price compatibility. Clinically proven, Metoo Fill has undergone a number of demanding clinical preliminaries to ensure that the fillers' performance continues to be incredible. Metoo Fill has official distributors in countries like UK, Thailand, Indonesia, Latvia and others. MayFill, the new filler from Maypharm, contains Multilayer Phasic Hyaluronic Acid based on the new R2 Technology (Rotation and Revolution), and lidocaine for a comfortable application, unlike Metoo Fill (CE).

Hyaluronic acid, which is found naturally in the body, works by retaining water within the skin and increasing its volume. MayFill HA filler is easy to modify because it reacts quickly to enzymes and normalizes unsatisfactory results. The result is smoother, firmer, younger-looking skin that can help erase the years. Also, compared to other treatments or devices there is relatively low risk with minimal downtime and faster recovery.

In Phasic multi-layer hyaluronic acid fillers, two layers exist together in the body creating even more natural results over time. This reduces the situation where crosslinked particles with a relatively high retrieval power come into direct contact with the treatment area and become unnatural.

In addition, Mayfill has reduced the incidence of edema. If hydration is insufficient, the edema hinders the prognosis of the intervention, which translates into low patient satisfaction. Mayfill provides sufficient hydration and can be used to contour and sculpt areas of the face, such as the cheekbones, lips or chin, to create a more balanced and symmetrical look. There are three types of MayFill: Volume, Deep and Light. They are also customizable, so you can choose the amount of product injected and the type of product to use based on the desired results.

Following its success in the Asian, UK, Middle Eastern and US markets, Maypharm continues its growth in the African and South American markets, discovering distributors for Sedy fill, Metox, MayFill and Mennus.

Please visit our website for detailed information: www.maypharm.net

Photo - https://mma.prnewswire.com/media/2005740...Photo - https://mma.prnewswire.com/media/2005741...

View original content: https://www.prnewswire.com/news-releases/maypharm-co-ltd-nuevo-relleno-de-acido-hialuronico-fasico-multicapa-con-lidocaina-301750830.html

NEXT NEWS